DIVERSIFIED HEALTHCARE T - DHC 5 5/8 08/01/42 (DHCNI) Stock Fundamental Analysis

USA • Nasdaq • NASDAQ:DHCNI • US25525P2065

17.05 USD
-0.06 (-0.35%)
Last: Feb 9, 2026, 10:16 AM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership News
Fundamental Rating

2

Overall DHCNI gets a fundamental rating of 2 out of 10. We evaluated DHCNI against 122 industry peers in the Diversified REITs industry. DHCNI may be in some trouble as it scores bad on both profitability and health. DHCNI does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

1

1. Profitability

1.1 Basic Checks

  • In the past year DHCNI has reported negative net income.
  • In the past year DHCNI had a positive cash flow from operations.
  • In the past 5 years DHCNI reported 4 times negative net income.
  • In multiple years DHCNI reported negative operating cash flow during the last 5 years.
DHCNI Yearly Net Income VS EBIT VS OCF VS FCFDHCNI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M 400M -400M

1.2 Ratios

  • The Return On Assets of DHCNI (-7.52%) is worse than 88.52% of its industry peers.
  • With a Return On Equity value of -20.85%, DHCNI is not doing good in the industry: 82.79% of the companies in the same industry are doing better.
Industry RankSector Rank
ROA -7.52%
ROE -20.85%
ROIC N/A
ROA(3y)-4.29%
ROA(5y)-2.48%
ROE(3y)-10.69%
ROE(5y)-6.22%
ROIC(3y)N/A
ROIC(5y)N/A
DHCNI Yearly ROA, ROE, ROICDHCNI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 -5 -10 -15

1.3 Margins

  • DHCNI has a worse Gross Margin (17.58%) than 92.62% of its industry peers.
  • DHCNI's Gross Margin has declined in the last couple of years.
  • DHCNI does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 17.58%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-6.33%
GM growth 5Y-20.05%
DHCNI Yearly Profit, Operating, Gross MarginsDHCNI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 60

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

3

2. Health

2.1 Basic Checks

  • DHCNI does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • The number of shares outstanding for DHCNI has been increased compared to 1 year ago.
  • DHCNI has more shares outstanding than it did 5 years ago.
  • Compared to 1 year ago, DHCNI has a worse debt to assets ratio.
DHCNI Yearly Shares OutstandingDHCNI Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M
DHCNI Yearly Total Debt VS Total AssetsDHCNI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B

2.2 Solvency

  • DHCNI has an Altman-Z score of 0.30. This is a bad value and indicates that DHCNI is not financially healthy and even has some risk of bankruptcy.
  • Looking at the Altman-Z score, with a value of 0.30, DHCNI is doing worse than 63.93% of the companies in the same industry.
  • A Debt/Equity ratio of 1.61 is on the high side and indicates that DHCNI has dependencies on debt financing.
  • With a Debt to Equity ratio value of 1.61, DHCNI is not doing good in the industry: 61.48% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity 1.61
Debt/FCF N/A
Altman-Z 0.3
ROIC/WACCN/A
WACC6.72%
DHCNI Yearly LT Debt VS Equity VS FCFDHCNI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B 2B 3B

2.3 Liquidity

  • DHCNI has a Current Ratio of 6.66. This indicates that DHCNI is financially healthy and has no problem in meeting its short term obligations.
  • With an excellent Current ratio value of 6.66, DHCNI belongs to the best of the industry, outperforming 96.72% of the companies in the same industry.
  • A Quick Ratio of 6.66 indicates that DHCNI has no problem at all paying its short term obligations.
  • With an excellent Quick ratio value of 6.66, DHCNI belongs to the best of the industry, outperforming 96.72% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 6.66
Quick Ratio 6.66
DHCNI Yearly Current Assets VS Current LiabilitesDHCNI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

3

3. Growth

3.1 Past

  • The earnings per share for DHCNI have decreased strongly by -22.32% in the last year.
  • DHCNI shows a small growth in Revenue. In the last year, the Revenue has grown by 4.10%.
  • DHCNI shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 7.53% yearly.
EPS 1Y (TTM)-22.32%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-3500%
Revenue 1Y (TTM)4.1%
Revenue growth 3Y2.63%
Revenue growth 5Y7.53%
Sales Q2Q%4.03%

3.2 Future

  • DHCNI is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 13.85% yearly.
  • The Revenue is expected to grow by 4.05% on average over the next years.
EPS Next Y-22.64%
EPS Next 2Y20.29%
EPS Next 3Y13.85%
EPS Next 5YN/A
Revenue Next Year4.4%
Revenue Next 2Y4.02%
Revenue Next 3Y4.05%
Revenue Next 5YN/A

3.3 Evolution

  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
DHCNI Yearly Revenue VS EstimatesDHCNI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 500M 1B 1.5B
DHCNI Yearly EPS VS EstimatesDHCNI Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 1 -1

More info and screens

Find the best growth stocksShow best growing peers

0

4. Valuation

4.1 Price/Earnings Ratio

  • DHCNI reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • Also next year DHCNI is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
DHCNI Price Earnings VS Forward Price EarningsDHCNI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20 40

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, DHCNI is valued more expensive than 90.98% of the companies in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 27.92
DHCNI Per share dataDHCNI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6

4.3 Compensation for Growth

  • DHCNI's earnings are expected to grow with 13.85% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y20.29%
EPS Next 3Y13.85%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

1

5. Dividend

5.1 Amount

  • DHCNI has a yearly dividend return of 0.65%, which is pretty low.
  • Compared to an average industry Dividend Yield of 6.81, DHCNI's dividend is way lower than its industry peers. On top of this 92.62% of the companies listed in the same industry pay a better dividend than DHCNI!
  • With a Dividend Yield of 0.65, DHCNI pays less dividend than the S&P500 average, which is at 1.81.
Industry RankSector Rank
Dividend Yield 0.65%

5.2 History

  • The dividend of DHCNI decreases each year by -45.60%.
  • DHCNI has been paying a dividend for over 5 years, so it has already some track record.
  • DHCNI has not decreased its dividend in the last 3 years.
Dividend Growth(5Y)-45.6%
Div Incr Years0
Div Non Decr Years3
DHCNI Yearly Dividends per shareDHCNI Yearly Dividends per shareYearly Dividends per share 2021 2022 2023 2024 2025 2026 0.2 0.4 0.6 0.8 1

5.3 Sustainability

  • The earnings of DHCNI are negative and hence is the payout ratio. DHCNI will probably not be able to sustain this dividend level.
DP-2.74%
EPS Next 2Y20.29%
EPS Next 3Y13.85%
DHCNI Yearly Income VS Free CF VS DividendDHCNI Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M -400M

More info and screens

Find the best dividend stocksShow peers with best dividend

DIVERSIFIED HEALTHCARE T - DHC 5 5/8 08/01/42

NASDAQ:DHCNI (2/9/2026, 10:16:13 AM)

17.05

-0.06 (-0.35%)

Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryDiversified REITs
Earnings (Last)11-03
Earnings (Next)02-23
Inst Owners76.96%
Inst Owner ChangeN/A
Ins Owners0.48%
Ins Owner ChangeN/A
Market Cap4.13B
Revenue(TTM)1.54B
Net Income(TTM)-352.11M
Analysts74.29
Price Target17.39 (1.99%)
Short Float %0.01%
Short Ratio0.49
Dividend
Industry RankSector Rank
Dividend Yield 0.65%
Yearly Dividend0.04
Dividend Growth(5Y)-45.6%
DP-2.74%
Div Incr Years0
Div Non Decr Years3
Ex-Date01-15
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-142.08%
Min EPS beat(2)-213.15%
Max EPS beat(2)-71.02%
EPS beat(4)1
Avg EPS beat(4)-46.14%
Min EPS beat(4)-213.15%
Max EPS beat(4)122.5%
EPS beat(8)2
Avg EPS beat(8)-24.79%
EPS beat(12)4
Avg EPS beat(12)-9.26%
EPS beat(16)4
Avg EPS beat(16)-20.93%
Revenue beat(2)1
Avg Revenue beat(2)0.09%
Min Revenue beat(2)-0.49%
Max Revenue beat(2)0.67%
Revenue beat(4)2
Avg Revenue beat(4)0.37%
Min Revenue beat(4)-0.49%
Max Revenue beat(4)1.32%
Revenue beat(8)2
Avg Revenue beat(8)-0.49%
Revenue beat(12)5
Avg Revenue beat(12)-0.29%
Revenue beat(16)5
Avg Revenue beat(16)-0.71%
PT rev (1m)-10.54%
PT rev (3m)-0.64%
EPS NQ rev (1m)0%
EPS NQ rev (3m)7.89%
EPS NY rev (1m)0%
EPS NY rev (3m)-54.55%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)1.04%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.71%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 2.68
P/FCF N/A
P/OCF 220.94
P/B 2.44
P/tB 2.44
EV/EBITDA 27.92
EPS(TTM)-1.37
EYN/A
EPS(NY)-0.58
Fwd EYN/A
FCF(TTM)-0.67
FCFYN/A
OCF(TTM)0.08
OCFY0.45%
SpS6.35
BVpS6.97
TBVpS6.97
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -7.52%
ROE -20.85%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 17.58%
FCFM N/A
ROA(3y)-4.29%
ROA(5y)-2.48%
ROE(3y)-10.69%
ROE(5y)-6.22%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-6.33%
GM growth 5Y-20.05%
F-Score6
Asset Turnover0.33
Health
Industry RankSector Rank
Debt/Equity 1.61
Debt/FCF N/A
Debt/EBITDA 11.41
Cap/Depr 65.29%
Cap/Sales 11.78%
Interest Coverage N/A
Cash Conversion 7.83%
Profit Quality N/A
Current Ratio 6.66
Quick Ratio 6.66
Altman-Z 0.3
F-Score6
WACC6.72%
ROIC/WACCN/A
Cap/Depr(3y)103.34%
Cap/Depr(5y)92.72%
Cap/Sales(3y)19.78%
Cap/Sales(5y)17.46%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-22.32%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-3500%
EPS Next Y-22.64%
EPS Next 2Y20.29%
EPS Next 3Y13.85%
EPS Next 5YN/A
Revenue 1Y (TTM)4.1%
Revenue growth 3Y2.63%
Revenue growth 5Y7.53%
Sales Q2Q%4.03%
Revenue Next Year4.4%
Revenue Next 2Y4.02%
Revenue Next 3Y4.05%
Revenue Next 5YN/A
EBIT growth 1Y46.47%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year382.47%
EBIT Next 3Y74.06%
EBIT Next 5YN/A
FCF growth 1Y38.56%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y30.8%
OCF growth 3YN/A
OCF growth 5Y-15.84%

DIVERSIFIED HEALTHCARE T - DHC 5 5/8 08/01/42 / DHCNI FAQ

Can you provide the ChartMill fundamental rating for DIVERSIFIED HEALTHCARE T - DHC 5 5/8 08/01/42?

ChartMill assigns a fundamental rating of 2 / 10 to DHCNI.


What is the valuation status of DIVERSIFIED HEALTHCARE T - DHC 5 5/8 08/01/42 (DHCNI) stock?

ChartMill assigns a valuation rating of 0 / 10 to DIVERSIFIED HEALTHCARE T - DHC 5 5/8 08/01/42 (DHCNI). This can be considered as Overvalued.


How profitable is DIVERSIFIED HEALTHCARE T - DHC 5 5/8 08/01/42 (DHCNI) stock?

DIVERSIFIED HEALTHCARE T - DHC 5 5/8 08/01/42 (DHCNI) has a profitability rating of 1 / 10.


How financially healthy is DIVERSIFIED HEALTHCARE T - DHC 5 5/8 08/01/42?

The financial health rating of DIVERSIFIED HEALTHCARE T - DHC 5 5/8 08/01/42 (DHCNI) is 3 / 10.


What is the expected EPS growth for DIVERSIFIED HEALTHCARE T - DHC 5 5/8 08/01/42 (DHCNI) stock?

The Earnings per Share (EPS) of DIVERSIFIED HEALTHCARE T - DHC 5 5/8 08/01/42 (DHCNI) is expected to decline by -22.64% in the next year.